Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEFINITY ultrasound contrast in focal renal lesions
CTR20171047Phase 3Completed
- Sponsor
- Lansource Medical Imaging
- Start
- Sep 2017
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of perflutren lipid microspheres in Renal focal lesion, sponsored by Lansource Medical Imaging. Started Sep 2017; status: completed.
02
Drugs
perflutren lipid microspheres
03
Conditions
Renal focal lesion
Beyond the preview
Go deeper on CTR20171047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171047.